Reva Medical has secured four new distribution deals with companies in seven European countries, including Russia, the Czech Republic, Poland and Estonia. The company plans to begin commercialization of its drug-eluting bioresorbable scaffold, the Fantom Encore, in each of these regions in three to 12 months.
Reva Medical expands distribution access into Europe
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.